DCF — BEAUMONT HEALTH - GROSSE POINTE
Enterprise Value: $-19.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-19.9M
Enterprise Value
$-13.1M
PV of Cash Flows
$-6.8M
PV of Terminal Value
$-11.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $273.6M | $4.7M | 2.0% | $-6.9M | $-6.3M |
| Year 2 | $281.8M | $7.6M | 3.0% | $-4.4M | $-3.7M |
| Year 3 | $290.3M | $10.8M | 4.0% | $-2.4M | $-1.8M |
| Year 4 | $299.0M | $12.6M | 4.0% | $-1.3M | $-0.9M |
| Year 5 | $308.0M | $13.7M | 4.0% | $-0.8M | $-0.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-19.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$265.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.012133269842085076
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5